share_log

HOOKIPA Pharma | DEF 14A: Definitive information statements

HOOKIPA Pharma | DEF 14A: Definitive information statements

HOOKIPA Pharma | DEF 14A：股东委托书决议
美股sec公告 ·  04/26 16:06
Moomoo AI 已提取核心信息
HOOKIPA Pharma Inc. announced the scheduling of its 2024 Annual Meeting of Stockholders to be held virtually on June 17, 2024. The meeting will address several key proposals, including the election of two Class II directors, the ratification of PwC Wirtschaftsprüfung GmbH as the independent auditor for the fiscal year ending December 31, 2024, and amendments to the company's certificate of incorporation to increase authorized shares of common stock to 400,000,000 and to effect a reverse stock split in the range of 1-for-2 to 1-for-10. The meeting will also cover any other business properly brought before the meeting. Stockholders are invited to attend online and vote electronically. The Notice of Annual Meeting and Proxy Statement detailing the agenda were dated April 26, 2024, with plans to mail the notice on the same date. The proxy materials are accessible at www.proxyvote.com, and stockholders are encouraged to review and cast their votes promptly.
HOOKIPA Pharma Inc. announced the scheduling of its 2024 Annual Meeting of Stockholders to be held virtually on June 17, 2024. The meeting will address several key proposals, including the election of two Class II directors, the ratification of PwC Wirtschaftsprüfung GmbH as the independent auditor for the fiscal year ending December 31, 2024, and amendments to the company's certificate of incorporation to increase authorized shares of common stock to 400,000,000 and to effect a reverse stock split in the range of 1-for-2 to 1-for-10. The meeting will also cover any other business properly brought before the meeting. Stockholders are invited to attend online and vote electronically. The Notice of Annual Meeting and Proxy Statement detailing the agenda were dated April 26, 2024, with plans to mail the notice on the same date. The proxy materials are accessible at www.proxyvote.com, and stockholders are encouraged to review and cast their votes promptly.
HOOKIPA Pharma Inc. 宣布其2024年年度股东大会定于2024年6月17日虚拟举行。会议将讨论几项关键提案，包括选举两名二类董事，批准普华永道经济审计有限责任公司为截至2024年12月31日的财政年度的独立审计师，以及修改公司注册证书，将普通股的法定股份增加到4亿股，并以1比2至1比10的比例进行反向股票分割。会议还将涵盖在会议之前适当提出的任何其他事项。邀请股东在线参加并进行电子投票。详细说明议程的年会通知和委托声明的日期为2024年4月26日，并计划在同一天邮寄通知。代理材料可在www.proxyvote.com上查阅，鼓励股东立即审查并投票。
HOOKIPA Pharma Inc. 宣布其2024年年度股东大会定于2024年6月17日虚拟举行。会议将讨论几项关键提案，包括选举两名二类董事，批准普华永道经济审计有限责任公司为截至2024年12月31日的财政年度的独立审计师，以及修改公司注册证书，将普通股的法定股份增加到4亿股，并以1比2至1比10的比例进行反向股票分割。会议还将涵盖在会议之前适当提出的任何其他事项。邀请股东在线参加并进行电子投票。详细说明议程的年会通知和委托声明的日期为2024年4月26日，并计划在同一天邮寄通知。代理材料可在www.proxyvote.com上查阅，鼓励股东立即审查并投票。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息